ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : University/Organization : California Cancer Consortium

Include trials that are no longer recruiting patients.

12 studies were found.
1.RecruitingBevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer
2.RecruitingBevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions: refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
3.RecruitingChemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Conditions: stage II non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; ...
4.RecruitingE7389 in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific
5.Not yet recruitingFenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer
Conditions: adenocarcinoma of the prostate; recurrent prostate cancer; stage II prostate cancer; stage III prostate cancer
6.RecruitingGTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
7.RecruitingGTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors
Conditions: adult solid tumor; Colon Cancer; Rectal Cancer
8.RecruitingImatinib Mesylate in Treating Patients With Refractory Metastatic and/or Unresectable Stomach Cancer
Conditions: recurrent gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
9.RecruitingOblimersen and Interferon alfa in Treating Patients With Metastatic Renal Cell Cancer
Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer
10.RecruitingOxaliplatin in Treating Patients With Liver Cancer
Conditions: advanced adult primary liver cancer; localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; ...
11.RecruitingPerifosine in Treating Patients With Recurrent Prostate Cancer
Conditions: adenocarcinoma of the prostate; recurrent prostate cancer
12.RecruitingUCN-01 in Treating Patients With Metastatic Melanoma
Conditions: Recurrent Melanoma; Stage IV Melanoma

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act